These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8875629)

  • 1. Prospects for prophylactic and therapeutic hepatitis C virus vaccines.
    Houghton M; Choo QL; Kuo G; Weiner A; Chien D; Ralston R; Urdea M; Moss B; Purcell R; Cummins L
    Princess Takamatsu Symp; 1995; 25():237-43. PubMed ID: 8875629
    [No Abstract]   [Full Text] [Related]  

  • 2. [New approaches to immune against hepatitis C virus].
    Sela B
    Harefuah; 2002 Dec; 141(12):1076-80, 1089. PubMed ID: 12534208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-vaccines against hepatitis B and C viral infections: a brief overview.
    Irshad M
    Trop Gastroenterol; 1999; 20(2):64-7. PubMed ID: 10484889
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of prophylactic and therapeutic vaccines against hepatitis C virus.
    Leroux-Roels G
    Expert Rev Vaccines; 2005 Jun; 4(3):351-71. PubMed ID: 16026249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Virology of hepatitis C virus].
    Hofmann H
    Wien Med Wochenschr; 2000; 150(23-24):463-6. PubMed ID: 11205175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer as a new mode of vaccination: implications for HCV.
    McDonnell WM
    Hepatology; 1993 Sep; 18(3):696-8. PubMed ID: 8395461
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C virus vaccines--progress and perspectives.
    Fauvelle C; Lepiller Q; Felmlee DJ; Fofana I; Habersetzer F; Stoll-Keller F; Baumert TF; Fafi-Kremer S
    Microb Pathog; 2013 May; 58():66-72. PubMed ID: 23499591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
    Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
    J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and vaccination for hepatitis C: present and future.
    Jawaid A; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.
    Leroux-Roels G; Depla E; Hulstaert F; Tobback L; Dincq S; Desmet J; Desombere I; Maertens G
    Vaccine; 2004 Aug; 22(23-24):3080-6. PubMed ID: 15297058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for a hepatitis C virus vaccine.
    Hsu HH; Abrignani S; Houghton M
    Clin Liver Dis; 1999 Nov; 3(4):901-15. PubMed ID: 11291258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for hepatitis C vaccine.
    Bhopale GM; Nanda RK
    Acta Virol; 2004; 48(4):215-21. PubMed ID: 15745044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus: models of immunopathogenesis and prophylaxis.
    Eckels DD; Flomenberg P; Gill JC
    Transfusion; 1996 Sep; 36(9):836-44. PubMed ID: 8823462
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
    Beaumont E; Roingeard P
    Hum Vaccin Immunother; 2013 May; 9(5):1112-8. PubMed ID: 23406827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.
    Arribillaga L; Sarobe P; Arina A; Gorraiz M; Borrás-Cuesta F; Ruiz J; Prieto J; Chen L; Melero I; Lasarte JJ
    Vaccine; 2005 May; 23(27):3493-9. PubMed ID: 15855007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C vaccine. Current status].
    Forns X
    Gastroenterol Hepatol; 1996; 19(6):317-9. PubMed ID: 8754421
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C vaccine approaches phase II trial.
    McNeil C
    J Natl Cancer Inst; 2006 Mar; 98(5):301-2. PubMed ID: 16507825
    [No Abstract]   [Full Text] [Related]  

  • 20. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.